Problem
Globally CVD affects approximately 32% of Diabetes patients, which is a major cause of morbidity accounting for half of the total deaths with Diabetes. CVD patients who die from coronary heart disease are often asymptomatic. It is a major challenge to calculate and implement risk scores (like ASCVD, CAD, Heart Age) in a busy clinic environment. Doctors don’t have the time to calculate them; while risks score reporting is essential for identifying high risk patients who need more careful monitoring by their doctors
Approach
Risk score calculation is a tedious job. The burden of calculating these scores falls on doctors. If the risk scores are overlooked at any stage of care, early diagnosis and treatment such as lifestyle modifications and medications will be delayed. So, in association with one of the top MNC pharmaceutical company we assisted doctors with early identification of high risk patients and set a healthy habit of pre-screening all diabetes patients.
Solution
Empower the doctor’s staff, to identify ASCVD risk of patients in the waiting area with the help of smart device Kribado
Impact
This initiative taken by the top MNC pharmaceutical company brought a paradigm shift in CAD screening of a Diabetes patient. In a short span of 3 months, 10,000 patients were screened saving hundreds of lives indirectly.